Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer

Cancer Causes and Control

Volumn 25, Issue 9, 2014, Pages 1131-1140

  Huss, Linnea ^a   Butt, Salma ^a   Borgquist, Signe ^a,b   Almquist, Martin ^a   Malm, Johan ^a   Manjer, Jonas ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Calcium; Mortality; PTH; Survival; Vitamin D

Indexed keywords

CALCIUM; PARATHYROID HORMONE; VITAMIN D;

BLOOD; BREAST TUMOR; DIET; EPIDEMIOLOGY; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; REGISTER; SURVIVAL; SWEDEN; WOMEN'S HEALTH;

BREAST NEOPLASMS; CALCIUM; DIET; FEMALE; HUMANS; MIDDLE AGED; PARATHYROID HORMONE; REGISTRIES; SURVIVAL ANALYSIS; SWEDEN; VITAMIN D; WOMEN'S HEALTH;

EID: 84939875012     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0413-3     Document Type: Article

References (56)

1. Colston KW (2008) Vitamin D and breast cancer risk. Best Pract Res Clin Endocrinol Metab 22(4):587–599. doi:10.1016/j.beem.2008.08.002
2. Rohan T (2007) Epidemiological studies of vitamin D and breast cancer. Nutr Rev 65(Supplement 1):80. doi:10.1301/nr.2007.aug.S80-S83
3. Grant WB (2010) An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production. Dermatoendocrinol 2(2):62–67. doi:10.4161/derm.2.2.13624
4. Chen W, Armstrong BK, Rahman B, Zheng R, Zhang S, Clements M (2013) Relationship between cancer survival and ambient ultraviolet B irradiance in China. Cancer Causes Control. doi:10.1007/s10552-013-0210-4
5. Robsahm TE, Tretli S, Dahlback A, Moan J (2004) Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 15(2):149–158. doi:10.1023/B:CACO.0000019494.34403.09
6. Porojnicu A, Robsahm TE, Berg JP, Moan J (2007) Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol 103(3–5):675–678. doi:10.1016/j.jsbmb.2006.12.031
7. Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J (2010) Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case–control study. Int J Cancer 127(9):2159–2168. doi:10.1002/ijc.25215
8. Gorham ED, Mohr SB, Garland FC, Garland CF (2009) Vitamin D for cancer prevention and survival. Clin Rev Bone Miner Metab 7(2):159–175. doi:10.1007/s12018-009-9028-8
9. Shao T, Klein P, Grossbard ML (2012) Vitamin D and breast cancer. Oncologist 17(1):36–45. doi:10.1634/theoncologist.2011-0278
10. Rose AA, Elser C, Ennis M, Goodwin PJ (2013) Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. Breast Cancer Res Treat 141(3):331–339. doi:10.1007/s10549-013-2713-9
11. Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99(21):1594–1602. doi:10.1093/jnci/djm204
12. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294(18):2336–2341. doi:10.1001/jama.294.18.2336
13. Linforth R, Anderson N, Hoey R, Nolan T, Downey S, Brady G, Ashcroft L, Bundred N (2002) Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival. Clinical Cancer 8(10):3172–3177
14. Hoey RP, Sanderson C, Iddon J, Brady G, Bundred NJ, Anderson NG (2003) The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells. Br J Cancer 88(4):567–573. doi:10.1038/sj.bjc.6600757
15. Birch MA, Carron JA, Scott M, Fraser WD, Gallagher JA (1995) Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor expression and mitogenic responses in human breast cancer cell lines. Br J Cancer 72(1):90–95
16. Cataisson C, Lieberherr M, Cros M, Gauville C, Graulet AM, Cotton J, Calvo F, de Vernejoul MC, Foley J, Bouizar Z (2000) Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cells. J Bone Miner 15(11):2129–2139. doi:10.1359/jbmr.2000.15.11.2129
17. Palmer M, Adami HO, Krusemo UB, Ljunghall S (1988) Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. Am J Epidemiol 127(5):1031–1040
18. Michels KB, Xue F, Brandt L, Ekbom A (2004) Hyperparathyroidism and subsequent incidence of breast cancer. Int J Cancer 110(3):449–451. doi:10.1002/ijc.20155
19. Nilsson IL, Zedenius J, Yin L, Ekbom A (2007) The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocr Relat Cancer 14(1):135–140. doi:10.1677/erc.1.01261
20. Pickard AL, Gridley G, Mellemkjae L, Johansen C, Kofoed-Enevoldsen A, Cantor KP, Brinton LA (2002) Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer 95(8):1611–1617. doi:10.1002/cncr.10846
21. Almquist M, Manjer J, Bondeson L, Bondeson A-G (2007) Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women. Cancer Causes Control 18(6):595–602. doi:10.1007/s10552-007-9001-0
22. Ramasamy I (2006) Recent advances in physiological calcium homeostasis. Clin Chem Lab Med 44(3):237–273. doi:10.1515/CCLM.2006.046
23. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G (2001) The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10(6):489–499
24. Butt S (2011) Reproductive factors and breast cancer—parity, breastfeeding and genetic predisposition in relation to risk and prognosis. Lund University, Faculty of Medicine Doctoral Dissertation Series, 10
25. Borgquist S, Anagnostaki L, Jirstrom K, Landberg G, Manjer J (2007) Breast tumours following combined hormone replacement therapy express favourable prognostic factors. Int J Cancer 120(10):2202–2207. doi:10.1002/ijc.22542
26. Wallström P, Department of Clinical Sciences M, Lund U, Emergency mMS, Internal M, Lunds u, Institutionen för kliniska vetenskaper M, Faculty of M, Medicin, Sektionen för AMK (2002) Diet, lifestyle, antioxidants, and biomarkers of cancer risk: an epidemiological report from the Malmö Diet and Cancer cohort. Dissertation/Thesis, Univ.-sjukhuset MAS, Malmö
27. Anker P, Wieland E, Ammann D, Dohner RE, Asper R, Simon W (1981) Neutral carrier based ion-selective electrode for the determination of total calcium in blood serum. Anal Chem 53(13):1970–1974
28. Gross M, Kost SB, Ennis B, Stumpf W, Kumar R (1986) Effect of 1,25-dihydroxyvitamin D3 on mouse mammary tumor (GR) cells: evidence for receptors, cellular uptake, inhibition of growth and alteration in morphology at physiologic concentrations of hormone. J Bone Miner Res 1(5):457–467. doi:10.1002/jbmr.5650010510
29. Simboli-Campbell M, Gagnon A, Franks DJ, Welsh J (1994) 1,25-Dihydroxyvitamin D3 translocates protein kinase C beta to nucleus and enhances plasma membrane association of protein kinase C alpha in renal epithelial cells. J Biol Chem 269(5):3257–3264
30. Fleet JC, DeSmet M, Johnson R, Li Y (2012) Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441(1):61–76. doi:10.1042/BJ20110744
31. Leyssens C, Verlinden L, Verstuyf A (2013) Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer. Endocr Relat Cancer 20(2):R31–R47. doi:10.1530/erc-12-0381
32. Grant WB, Peiris AN (2012) Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans. Dermatoendocrinol 4(2):85–94. doi:10.4161/derm.19667
33. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27(23):3757–3763. doi:10.1200/JCO.2008.20.0725
34. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE (2012) Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23(2):363–370. doi:10.1007/s10552-011-9885-6
35. Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, Vandorpe T, Brouckaert O, Peuteman G, Laenen A, Verlinden L, Kriebitzsch C, Dieudonne AS, Paridaens R, Neven P, Christiaens MR, Bouillon R, Wildiers H (2012) Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis 33(7):1319–1326. doi:10.1093/carcin/bgs187
36. Villasenor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A, Neuhouser ML (2013) Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control 24(4):759–767. doi:10.1007/s10552-013-0158-4
37. Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J (2011) Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 13(4):R74. doi:10.1186/bcr2920
38. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58. doi:10.1210/jc.2010-2704
39. Brandstedt J, Almquist M, Manjer J, Malm J (2012) Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case–control study. Cancer Causes Control 23(8):1377–1385. doi:10.1007/s10552-012-9948-3
40. Isowa S, Shimo T, Ibaragi S, Kurio N, Okui T, Matsubara K, Hassan NM, Kishimoto K, Sasaki A (2010) PTHrP regulates angiogenesis and bone resorption via VEGF expression. Anticancer Res 30(7):2755–2767
41. Ankrah-Tetteh T, Wijeratne S, Swaminathan R (2008) Intraindividual variation in serum thyroid hormones, parathyroid hormone and insulin-like growth factor-1. Ann Clin Biochem 45(Pt 2):167–169. doi:10.1258/acb.2007.007103
42. Viljoen A, Singh DK, Twomey PJ, Farrington K (2008) Analytical quality goals for parathyroid hormone based on biological variation. Clin Chem Lab Med 46(10):1438–1442. doi:10.1515/CCLM.2008.275
43. Thaw SS, Sahmoun A, Schwartz GG (2012) Serum calcium, tumor size, and hormone receptor status in women with untreated breast cancer. Cancer Biol Ther 13(7):467–471. doi:10.4161/cbt.19606
44. Almquist M, Anagnostaki L, Bondeson L, Bondeson AG, Borgquist S, Landberg G, Malina J, Malm J, Manjer J (2009) Serum calcium and tumour aggressiveness in breast cancer: a prospective study of 7847 women. Eur J Cancer Prev 18(5):354–360. doi:10.1097/CEJ.0b013e32832c386f
45. Meng JE, Hovey KM, Wactawski-Wende J, Andrews CA, Lamonte MJ, Horst RL, Genco RJ, Millen AE (2012) Intraindividual variation in plasma 25-hydroxyvitamin D measures 5 years apart among postmenopausal women. Cancer Epidemiol Biomarkers Prev 21(6):916–924. doi:10.1158/1055-9965.EPI-12-0026
46. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15(3):255–265. doi:10.1023/B:CACO.0000024245.24880.8a
47. Gallagher SK, Johnson LK, Milne DB (1989) Short-term and long-term variability of indices related to nutritional status. I: Ca, Cu, Fe, Mg, and Zn. Clin Chem 35(3):369–373
48. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, Minchinela J, Perich C, Simon M (1999) Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 59(7):491–500
49. Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92(1):4–8. doi:10.1016/j.pbiomolbio.2006.02.016
50. Need AG, O’Loughlin PD, Morris HA, Horowitz M, Nordin BE (2004) The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocrinol Metab 89(4):1646–1649
51. Lips P, van Schoor NM, de Jongh RT (2014) Diet, sun, and lifestyle as determinants of vitamin D status. Ann N Y Acad Sci. doi:10.1111/nyas.12443
52. Welfare NBoHa (2010) Cause of death statistics; history, production and reliability (in Swedish). http://www.socialstyrelsen.se/publikationer2010/2010-4-33. Accessed 21 Dec 2013
53. Johansson LA, Bjorkenstam C, Westerling R (2009) Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995. J Clin Epidemiol 62(11):1202–1209. doi:10.1016/j.jclinepi.2009.01.010
54. Brock K, Huang WY, Fraser DR, Ke L, Tseng M, Stolzenberg-Solomon R, Peters U, Ahn J, Purdue M, Mason RS, McCarty C, Ziegler RG, Graubard B (2010) Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol 121(1–2):462–466. doi:10.1016/j.jsbmb.2010.03.091
55. Pajares B, Pollan M, Martin M, Mackey JR, Lluch A, Gavila J, Vogel C, Ruiz-Borrego M, Calvo L, Pienkowski T, Rodriguez-Lescure A, Segui MA, Tredan O, Anton A, Ramos M, Del Carmen M, Rodriguez-Martin C, Carrasco E, Alba E (2013) Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis. Breast Cancer Res 15(6):R105. doi:10.1186/bcr3572
56. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3):690–693